Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.

ClinicalTrials.gov ID: NCT02553772

Public ClinicalTrials.gov record NCT02553772. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 10:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-masked, Randomized Study to Compare the Safety and Efficacy of the OM3 Tear Formulation With REFRESH OPTIVE® ADVANCED Unit Dose for 3 Months in Patients With Dry Eye Disease

Study identification

NCT ID
NCT02553772
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allergan
Industry
Enrollment
242 participants

Conditions and interventions

Interventions

  • Carboxymethylcellulose Based Eye Drop Drug
  • Carboxymethylcellulose Sodium 0.5% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 5, 2016
Primary completion
Sep 8, 2016
Completion
Sep 8, 2016
Last update posted
Nov 16, 2017

2016

United States locations

U.S. sites
10
U.S. states
6
U.S. cities
10
Facility City State ZIP Site status
The Private Practice of Milton Hom, OD Azusa California 91702
Havana Research Institute LLC Burbank California 91506
Lugene Eye Institute Glendale California 91204
Eric M. White, OD, INC San Diego California 92123
Moyes Eye Center, PC Kansas City Missouri 64154
Ophthalmology Associates St Louis Missouri 63131
Rochester Ophthalmological Group, PC Rochester New York 14618
Charlotte Eye Ear Nose Charlotte North Carolina 28210
Scott and Christie and Associate Cranberry Township Pennsylvania 16066
Texan Eye Austin Texas 78731

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02553772, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2017 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02553772 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →